UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Natural killer cells in cancer biology and therapy

Molecular cancer, 2020-08, Vol.19 (1), p.120-120, Article 120

2020

Volltextzugriff (PDF)

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Cell research, 2022-05, Vol.32 (5), p.477-490

2022

Volltextzugriff (PDF)

Molecular Subtyping of Triple‐Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

The oncologist (Dayton, Ohio), 2020-10, Vol.25 (10), p.e1481-e1491

2020

Volltextzugriff (PDF)

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort

Cancer, 2022-05, Vol.128 (9), p.1748-1756

2022

Volltextzugriff (PDF)

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

Journal of hematology and oncology, 2021-06, Vol.14 (1), p.98-25, Article 98

2021

Volltextzugriff (PDF)

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Cell research, 2021-02, Vol.31 (2), p.178-186

2021

Volltextzugriff (PDF)

Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study

Scientific reports, 2017-03, Vol.7 (1), p.45411-45411, Article 45411

2017

Volltextzugriff (PDF)

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

Clinical cancer research, 2019-08, Vol.25 (16), p.5002-5014

2019

Volltextzugriff (PDF)

HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis

Cancer, 2024-03, Vol.130 (6), p.851-862

2024

Volltextzugriff (PDF)

Breast cancer in China

The lancet oncology, 2014-06, Vol.15 (7), p.e279-e289

2014

Volltextzugriff (PDF)

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Nature communications, 2022-02, Vol.13 (1), p.791-791, Article 791

2022

Volltextzugriff (PDF)

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.514-522

2017

Volltextzugriff (PDF)

Deubiquitinase ubiquitin‐specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells

Cancer science, 2019-04, Vol.110 (4), p.1268-1278

2019

Volltextzugriff (PDF)

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription

Molecular cancer, 2019-12, Vol.18 (1), p.187-187, Article 187

2019

Volltextzugriff (PDF)

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics

Breast cancer research and treatment, 2019-01, Vol.173 (1), p.225-237

2019

Volltextzugriff (PDF)

In vivo CRISPR screens identify RhoV as a pro‐metastasis factor of triple‐negative breast cancer

Cancer science, 2023-06, Vol.114 (6), p.2375-2385

2023

Volltextzugriff (PDF)

Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions

Cancer communications (London, England), 2023-03, Vol.43 (3), p.297-337

2023

Volltextzugriff (PDF)

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression

Cell death and differentiation, 2022-04, Vol.29 (4), p.861-873

2022

Volltextzugriff (PDF)

Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling

Cancer cell, 2019-01, Vol.35 (1), p.64-80.e7

2019

Volltextzugriff (PDF)

The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing

International journal of cancer, 2017-07, Vol.141 (1), p.129-142

2017

Volltextzugriff (PDF)

Integrative 3′ Untranslated Region‐Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple‐Negative Breast Cancer

The oncologist (Dayton, Ohio), 2019-01, Vol.24 (1), p.22-30

2019

Volltextzugriff (PDF)

Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2

Genes & development, 2020-10, Vol.34 (19-20), p.1310-1315

2020

Volltextzugriff (PDF)

Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (20), p.5780-5792

2018

Volltextzugriff (PDF)

Integration of whole‐genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple‐negative breast cancer

International journal of cancer, 2019-11, Vol.145 (10), p.2850-2860

2019

Volltextzugriff (PDF)

1 – 25 von 828

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(713)
Mit Volltextzugriff
(719)

Publikationsform

Sprache

Englisch
(767)
Chinesisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(61)
Breast Cancer Research And Treatment
(59)
Oncotarget
(24)
Plos One
(24)
Scientific Reports
(16)
Clinical Cancer Research
(15)
Chinese Medical Journal
(12)
中华医学杂志
(12)
Annals Of Surgical Oncology
(11)
Bmc Cancer
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Natural killer cells in cancer biology and therapy

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Molecular Subtyping of Triple‐Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance

De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort

Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response

Molecular subtyping and genomic profiling expand precision medicine in refractory metastatic triple-negative breast cancer: the FUTURE trial

Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study

Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer

HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis

Breast cancer in China

Copy number amplification of ENSA promotes the progression of triple-negative breast cancer via cholesterol biosynthesis

Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies

RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer

Deubiquitinase ubiquitin‐specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells

LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription

Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics

In vivo CRISPR screens identify RhoV as a pro‐metastasis factor of triple‐negative breast cancer

Resistance to antibody‐drug conjugates in breast cancer: mechanisms and solutions

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression

Tinagl1 Suppresses Triple-Negative Breast Cancer Progression and Metastasis by Simultaneously Inhibiting Integrin/FAK and EGFR Signaling

The spectrum of BRCA mutations and characteristics of BRCA‐associated breast cancers in China: Screening of 2,991 patients and 1,043 controls by next‐generation sequencing

Integrative 3′ Untranslated Region‐Based Model to Identify Patients with Low Risk of Axillary Lymph Node Metastasis in Operable Triple‐Negative Breast Cancer

Deubiquitinase USP20 promotes breast cancer metastasis by stabilizing SNAI2

Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer

Integration of whole‐genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple‐negative breast cancer

Suchergebnisse filtern